Listed six days ago
- Exposure to Hong Kong’s evolving regulatory landscape.
- Opportunity to lead the registration of China‘s first MSC therapy in Hong Kong.
- Competitive compensation package aligned with global standards.
- Exposure to Hong Kong’s evolving regulatory landscape.
- Opportunity to lead the registration of China‘s first MSC therapy in Hong Kong.
- Competitive compensation package aligned with global standards.
We are a pioneering biopharmaceutical company that successfully launched the first MSC-based cell therapy approved in China.
We are a pioneering biopharmaceutical company that successfully launched the first MSC-based cell therapy approved in China.
6d ago
6d ago